Future indications and clinical management for fecal microbiota transplantation (FMT) in immuno-oncology.

Jamal, Rahima; Messaoudene, Meriem; de Figuieredo, Marina; Routy, Bertrand

Jamal, Rahima; Messaoudene, Meriem; de Figuieredo, Marina; Routy, Bertrand.

Afiliação

Jamal R; University of Montreal Research Center (CRCHUM), Montreal, QC, Canada; Hematology-Oncology Division, Department of Medicine, University of Montreal Healthcare Centre (CHUM), Montreal, QC, Canada.
Messaoudene M; University of Montreal Research Center (CRCHUM), Montreal, QC, Canada.
de Figuieredo M; University of Montreal Research Center (CRCHUM), Montreal, QC, Canada; Hematology-Oncology Division, Department of Medicine, University of Montreal Healthcare Centre (CHUM), Montreal, QC, Canada.
Routy B; University of Montreal Research Center (CRCHUM), Montreal, QC, Canada; Hematology-Oncology Division, Department of Medicine, University of Montreal Healthcare Centre (CHUM), Montreal, QC, Canada. Electronic address: bertrand.routy@umontreal.ca.

Semin Immunol ; 67: 101754, 2023 05.

Article em En | MEDLINE | ID: mdl-37003055

Assuntos

Microbiota; Neoplasias; Humanos; Animais; Camundongos; Transplante de Microbiota Fecal/efeitos adversos; Inibidores de Checkpoint Imunológico; Resultado do Tratamento; Neoplasias/terapia; Neoplasias/etiologia

Palavras-chave

Cancer; Fecal microbiota transplantation; Gut microbiota; Immune checkpoint inhibitors; Immuno-oncology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbiota / Neoplasias Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google